Candriam Equities L Biotechnology Class R GBP Cap

Performance History31/08/2020
Growth of 1,000 (GBP) Advanced Graph
Candriam Equities L Biotechnology Class R GBP Cap
Fund-3.516.6-5.030.87.4
+/-Cat0.56.33.010.6-6.9
+/-B’mrk2.75.5-1.810.5-4.5
 
Key Stats
NAV
17/09/2020
 GBP 298.46
Day Change 0.51%
Morningstar Category™ Sector Equity Biotechnology
IA (formerly IMA) Sector Specialist
ISIN LU1269736911
Fund Size (Mil)
17/09/2020
 USD 2017.80
Share Class Size (Mil)
17/09/2020
 GBP 0.58
Max Initial Charge 3.50%
Ongoing Charge
06/04/2020
  1.10%
Morningstar Research
Analyst Report

A team of highly qualified biotechnology experts led by one of the industry’s most seasoned investors in the field, and a proven process, give this fund an edge. Under our enhanced ratings framework, which puts more focus on fees and expected...

Click here to read this analyst report on the underlying fund.
Morningstar Pillars
PeopleAbove Average
ParentAverage
ProcessAbove Average
Performance
Price
Investment Objective: Candriam Equities L Biotechnology Class R GBP Cap
The objective of the sub-fund is to benefit from the performance of the market in global equities of companies in the biotechnology sector, on the basis of discretionary management.
Returns
Trailing Returns (GBP)17/09/2020
YTD12.55
3 Years Annualised10.78
5 Years Annualised*8.93
10 Years Annualised*19.32
12 Month Yield 0.00
Management
Manager Name
Start Date
Rudi Van den Eynde
06/04/2000
Servaas Michielssens
01/01/2019
Inception Date
08/03/2016
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDNASDAQ Biotechnology TR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Candriam Equities L Biotechnology Class R GBP Cap31/07/2020
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock93.190.0093.19
Bond0.000.000.00
Property0.000.000.00
Cash6.810.006.81
Other0.000.000.00
Top 5 Regions%
United States83.83
Eurozone8.24
Asia - Emerging3.07
Europe - ex Euro2.68
Japan1.07
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Amgen IncHealthcareHealthcare6.87
Vertex Pharmaceuticals IncHealthcareHealthcare6.80
Regeneron Pharmaceuticals IncHealthcareHealthcare5.84
Gilead Sciences IncHealthcareHealthcare5.46
Biogen IncHealthcareHealthcare3.51
Candriam Equities L Biotechnology Class R GBP Cap

Related

* This share class has performance data calculated prior to the inception date, 2016-03-08. This is based upon a simulated/extended track record, using the track record of Candriam Eqs L Biotech C USD Cap (ISIN: LU0108459040), and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here.
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies